TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

Immunity

Volumn 24, Issue 2, 2006, Pages 179-189

  Veldhoen, Marc ^a   Hocking, Richard J ^a   Atkins, Christopher J ^b   Locksley, Richard M ^b   Stockinger, Brigitta ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; PROTEIN; PROTEIN HLX; SMAD7 PROTEIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; INTERLEUKIN 1 RECEPTOR; MEMBRANE PROTEIN; TGFB1 PROTEIN, MOUSE; TIRAP PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; COCULTURE; CYTOKINE PRODUCTION; LYMPHOCYTE CULTURE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DENDRITIC CELL; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; INTERLEUKIN-17; LYMPHOCYTE SUBSETS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, INTERLEUKIN-1; SMAD7 PROTEIN; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 32244442562     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2006.01.001     Document Type: Article

References (70)

1. S. Aggarwal, N. Ghilardi, M.H. Xie, F.J. de Sauvage, and A.L. Gurney Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 J. Biol. Chem. 278 2003 1910 1914
2. J.B. Allen, C.L. Manthey, A.R. Hand, K. Ohura, L. Ellingsworth, and S.M. Wahl Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta J. Exp. Med. 171 1990 231 247
3. A.R. Almeida, N. Legrand, M. Papiernik, and A.A. Freitas Homeostasis of peripheral CD4(+) T cells: IL-2Ralpha and IL-2 shape a population of regulatory cells that controls CD4(+) T cell numbers J. Immunol. 169 2002 4850 4860
4. T. Alonzi, E. Fattori, D. Lazzaro, P. Costa, L. Probert, G. Kollias, F. De Benedetti, V. Poli, and G. Ciliberto Interleukin 6 is required for the development of collagen-induced arthritis J. Exp. Med. 187 1998 461 468
5. O. Annacker, O. Burlen-Defranoux, R. Pimenta-Araujo, A. Cumano, and A. Bandeira Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment J. Immunol. 164 2000 3573 3580
6. T. Barthlott, H. Moncrieffe, M. Veldhoen, C.J. Atkins, J. Christensen, A. O'Garra, and B. Stockinger CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production Int. Immunol. 17 2005 279 288
7. M. Belghith, J.A. Bluestone, S. Barriot, J. Megret, J.F. Bach, and L. Chatenoud TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes Nat. Med. 9 2003 1202 1208
8. E. Bettelli, B. Sullivan, S.J. Szabo, R.A. Sobel, L.H. Glimcher, and V.K. Kuchroo Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis J. Exp. Med. 200 2004 79 87
9. C.H. Chen, C. Seguin-Devaux, N.A. Burke, T.B. Oriss, S.C. Watkins, N. Clipstone, and A. Ray Transforming growth factor beta blocks Tec kinase phosphorylation, Ca2+ influx, and NFATc translocation causing inhibition of T cell differentiation J. Exp. Med. 197 2003 1689 1699
10. Y. Chen, P. Thai, Y.H. Zhao, Y.S. Ho, M.M. DeSouza, and R. Wu Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop J. Biol. Chem. 278 2003 17036 17043
11. D.J. Cua, J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, and T. Churakova Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain Nature 421 2003 744 748
12. M. de la Rosa, S. Rutz, H. Dorninger, and A. Scheffold Interleukin-2 is essential for CD4+CD25+ regulatory T cell function Eur. J. Immunol. 34 2004 2480 2488
13. H.P. Eugster, K. Frei, M. Kopf, H. Lassmann, and A. Fontana IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis Eur. J. Immunol. 28 1998 2178 2187
14. L. Fahlen, S. Read, L. Gorelik, S.D. Hurst, R.L. Coffman, R.A. Flavell, and F. Powrie T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells J. Exp. Med. 201 2005 737 746
15. R.A. Fava, N.J. Olsen, A.E. Postlethwaite, K.N. Broadley, J.M. Davidson, L.B. Nanney, C. Lucas, and A.S. Townes Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia J. Exp. Med. 173 1991 1121 1132
16. F.W. Fitch, M.D. McKisic, D.W. Lancki, and T.F. Gajewski Differential regulation of murine T lymphocyte subsets Annu. Rev. Immunol. 11 1993 29 48
17. J.D. Fontenot, and A.Y. Rudensky A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 Nat. Immunol. 6 2005 331 337
18. J.D. Fontenot, J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky Regulatory T cell lineage specification by the forkhead transcription factor foxp3 Immunity 22 2005 329 341
19. F. Fossiez, J. Banchereau, R. Murray, C. Van Kooten, P. Garrone, and S. Lebecque Interleukin-17 Int. Rev. Immunol. 16 1998 541 551
20. L. Gorelik, and R.A. Flavell Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease Immunity 12 2000 171 181
21. L. Gorelik, and R.A. Flavell Transforming growth factor-beta in T-cell biology Nat. Rev. Immunol. 2 2002 46 53
22. L. Gorelik, P.E. Fields, and R.A. Flavell Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression J. Immunol. 165 2000 4773 4777
23. L. Gorelik, S. Constant, and R.A. Flavell Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation J. Exp. Med. 195 2002 1499 1505
24. L.E. Harrington, R.D. Hatton, P.R. Mangan, H. Turner, T.L. Murphy, K.M. Murphy, and C.T. Weaver Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat. Immunol. 6 2005 1123 1132
25. H. Hata, N. Sakaguchi, H. Yoshitomi, Y. Iwakura, K. Sekikawa, Y. Azuma, C. Kanai, E. Moriizumi, T. Nomura, T. Nakamura, and S. Sakaguchi Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice J. Clin. Invest. 114 2004 582 588
26. H. Hayashi, S. Abdollah, Y. Qiu, J. Cai, Y.Y. Xu, B.W. Grinnell, M.A. Richardson, J.N. Topper, M.A. Gimbrone Jr., J.L. Wrana, and D. Falb The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling Cell 89 1997 1165 1173
27. V.L. Heath, E.E. Murphy, C. Crain, M.G. Tomlinson, and A. O'Garra TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression Eur. J. Immunol. 30 2000 2639 2649
28. T. Kaisho, O. Takeuchi, T. Kawai, K. Hoshino, and S. Akira Endotoxin-induced maturation of MyD88-deficient dendritic cells J. Immunol. 166 2001 5688 5694
29. T. Kinugasa, T. Sakaguchi, X. Gu, and H.C. Reinecker Claudins regulate the intestinal barrier in response to immune mediators Gastroenterology 118 2000 1001 1011
30. J.K. Kolls, and A. Linden Interleukin-17 family members and inflammation Immunity 21 2004 467 476
31. A.B. Kulkarni, C.G. Huh, D. Becker, A. Geiser, M. Lyght, K.C. Flanders, A.B. Roberts, M.B. Sporn, J.M. Ward, and S. Karlsson Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death Proc. Natl. Acad. Sci. USA 90 1993 770 774
32. C.L. Langrish, Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, J.D. Sedgwick, T. McClanahan, R.A. Kastelein, and D.J. Cua IL-23 drives a pathogenic T cell population that induces autoimmune inflammation J. Exp. Med. 201 2005 233 240
33. J.J. Letterio TGF-beta signaling in T cells: roles in lymphoid and epithelial neoplasia Oncogene 24 2005 5701 5712
34. J.J. Letterio, and A.B. Roberts Regulation of immune responses by TGF-beta Annu. Rev. Immunol. 16 1998 137 161
35. J.T. Lin, S.L. Martin, L. Xia, and J.D. Gorham TGF-beta 1 uses distinct mechanisms to inhibit IFN-gamma expression in CD4+ T cells at priming and at recall: differential involvement of Stat4 and T-bet J. Immunol. 174 2005 5950 5958
36. A.E. Lovett-Racke, A.E. Rocchini, J. Choy, S.C. Northrop, R.Z. Hussain, R.B. Ratts, D. Sikder, and M.K. Racke Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes Immunity 21 2004 719 731
37. G. Lugo-Villarino, S. Ito, D.M. Klinman, and L.H. Glimcher The adjuvant activity of CpG DNA requires T-bet expression in dendritic cells Proc. Natl. Acad. Sci. USA 102 2005 13248 13253
38. K.J. Maloy, and F. Powrie Regulatory T cells in the control of immune pathology Nat. Immunol. 2 2001 816 822
39. S.C. McKarns, and N.E. Kaminski TGF-beta 1 differentially regulates IL-2 expression and [3H]-thymidine incorporation in CD3 epsilon mAb- and CD28 mAb-activated splenocytes and thymocytes Immunopharmacology 48 2000 101 115
40. K.W. Moore, R. de Waal Malefyt, R.L. Coffman, and A. O'Garra Interleukin-10 and the interleukin-10 receptor Annu. Rev. Immunol. 19 2001 683 765
41. A.C. Mullen, A.S. Hutchins, F.A. High, H.W. Lee, K.J. Sykes, L.A. Chodosh, and S.L. Reiner Hlx is induced by and genetically interacts with T-bet to promote heritable T(H)1 gene induction Nat. Immunol. 3 2002 652 658
42. C.A. Murphy, C.L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R.A. Kastelein, J.D. Sedgwick, and D.J. Cua Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation J. Exp. Med. 198 2003 1951 1957
43. S. Nakae, Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses Immunity 17 2002 375 387
44. K. Nakamura, A. Kitani, and W. Strober Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta J. Exp. Med. 194 2001 629 644
45. A. Nakao, M. Afrakhte, A. Moren, T. Nakayama, J.L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N.E. Heldin, C.H. Heldin, and P. ten Dijke Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling Nature 389 1997 631 635
46. A. O'Garra, P.L. Vieira, P. Vieira, and A.E. Goldfeld IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage J. Clin. Invest. 114 2004 1372 1378
47. A. Ogawa, A. Andoh, Y. Araki, T. Bamba, and Y. Fujiyama Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice Clin. Immunol. 110 2004 55 62
48. S. Ohshima, Y. Saeki, T. Mima, M. Sasai, K. Nishioka, S. Nomura, M. Kopf, Y. Katada, T. Tanaka, M. Suemura, and T. Kishimoto Interleukin 6 plays a key role in the development of antigen-induced arthritis Proc. Natl. Acad. Sci. USA 95 1998 8222 8226
49. Y. Okuda, S. Sakoda, C.C. Bernard, H. Fujimura, Y. Saeki, T. Kishimoto, and T. Yanagihara IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein Int. Immunol. 10 1998 703 708
50. B. Oppmann, R. Lesley, B. Blom, J.C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, and K. Singh Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 Immunity 13 2000 715 725
51. H. Park, Z. Li, X.O. Yang, S.H. Chang, R. Nurieva, Y.H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 Nat. Immunol. 6 2005 1133 1141
52. C. Pasare, and R. Medzhitov Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells Science 299 2003 1033 1036
53. C.A. Piccirillo, J.J. Letterio, A.M. Thornton, R.S. McHugh, M. Mamura, H. Mizuhara, and E.M. Shevach CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness J. Exp. Med. 196 2002 237 246
54. F. Powrie T cells in inflammatory bowel disease: protective and pathogenic roles Immunity 3 1995 171 174
55. C. Reis e Sousa Toll-like receptors and dendritic cells: for whom the bug tolls Semin. Immunol. 16 2004 27 34
56. I. Rochman, W.E. Paul, and S.Z. Ben-Sasson IL-6 increases primed cell expansion and survival J. Immunol. 174 2005 4761 4767
57. S. Sakaguchi Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self Nat. Immunol. 6 2005 345 352
58. Y. Shi, and J. Massague Mechanisms of TGF-beta signaling from cell membrane to the nucleus Cell 113 2003 685 700
59. M.M. Shull, I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, and D. Calvin Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease Nature 359 1992 693 699
60. D.B. Stetson, M. Mohrs, R.L. Reinhardt, J.L. Baron, Z.E. Wang, L. Gapin, M. Kronenberg, and R.M. Locksley Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function J. Exp. Med. 198 2003 1069 1076
61. B. Stockinger, and B. Hausmann Functional recognition of in vivo processed self antigen Int. Immunol. 6 1994 247 254
62. S.J. Szabo, A.S. Dighe, U. Gubler, and K.M. Murphy Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells J. Exp. Med. 185 1997 817 824
63. S.J. Szabo, S.T. Kim, G.L. Costa, X. Zhang, C.G. Fathman, and L.H. Glimcher A novel transcription factor, T-bet, directs Th1 lineage commitment Cell 100 2000 655 669
64. T. Taga, and T. Kishimoto Gp130 and the interleukin-6 family of cytokines Annu. Rev. Immunol. 15 1997 797 819
65. A.M. Thornton, and E.M. Shevach CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production J. Exp. Med. 188 1998 287 296
66. L. Ulloa, J. Doody, and J. Massague Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway Nature 397 1999 710 713
67. S. Vanden Eijnden, S. Goriely, D. De Wit, F. Willems, and M. Goldman IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human Eur. J. Immunol. 35 2005 469 475
68. S.M. Wahl Transforming growth factor beta: the good, the bad, and the ugly J. Exp. Med. 180 1994 1587 1590
69. S.M. Wahl, J.B. Allen, G.L. Costa, H.L. Wong, and J.R. Dasch Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta J. Exp. Med. 177 1993 225 230
70. W. Zheng, and R.A. Flavell The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells Cell 89 1997 587 596